• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION TRUEPATH; WIRE, GUIDE, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION TRUEPATH; WIRE, GUIDE, CATHETER Back to Search Results
Model Number 39539
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/12/2018
Event Type  malfunction  
Event Description
It was reported that the device broke.The chronic total occlusion target lesion was located in the moderately tortuous and severely calcified superficial femoral artery.A truepath was selected for use.During procedure, it was noted under fluoroscopy that part of the radiopaque marker of the tip was thin at about 5mm while manipulating.It was then judged to be broken and was simply pulled out from the patient's body.The device was visually inspected outside the patient's body and there were no abnormalities observed.The procedure was completed wit another of the same device.No patient complications were reported and the patient was stable.
 
Manufacturer Narrative
Device evaluated by manufacturer: the device was returned for analysis.Returned product consisted of a truepath device.The control unit, motor housing, working length, tip housing/tip were microscopically examined.Saline were present on the shaft and tip of the device.Majority of the proximal end of the coil at the tip was stretched and coil at the distal end of the tip was unraveled.A photo was returned and attached to the complaint record.The photo was reviewed by the personnel from the mg cis (maple grove complaint investigation site) and it was found that the light area is where the confirmed unraveled coil was located on the device.Inspection of the remainder of the device presented no other damage or irregularities.
 
Event Description
It was reported that the device broke.The chronic total occlusion target lesion was located in the moderately tortuous and severely calcified superficial femoral artery.A truepath was selected for use.During procedure, it was noted under fluoroscopy that part of the radiopaque marker of the tip was thin at about 5mm while manipulating.It was then judged to be broken and was simply pulled out from the patient's body.The device was visually inspected outside the patient's body and there were no abnormalities observed.The procedure was completed wit another of the same device.No patient complications were reported and the patient was stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRUEPATH
Type of Device
WIRE, GUIDE, CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8142085
MDR Text Key129635055
Report Number2134265-2018-63661
Device Sequence Number1
Product Code PDU
UDI-Device Identifier08714729820284
UDI-Public08714729820284
Combination Product (y/n)N
PMA/PMN Number
K140288
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 01/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/13/2020
Device Model Number39539
Device Catalogue Number39539
Device Lot Number0021882408
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/10/2018
Initial Date Manufacturer Received 11/13/2018
Initial Date FDA Received12/07/2018
Supplement Dates Manufacturer Received12/17/2018
Supplement Dates FDA Received01/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
INTRODUCER SHEATH: DESTINATION 6F
-
-